EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, CHGCF: Chugai Pharmaceutical Co. Ltd

17 Oct 2025
LAST:

48.59

CHANGE:
 0.46		OPEN:
43.56		HIGH:
48.59		ASK:
0.00		VOLUME:
1.2K
CHG(%):
0.94		PREV:
49.05		LOW:
43.56		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
17 Oct 2543.5648.5943.5648.591.2K
16 Oct 2549.0549.0648.9049.05800
13 Oct 2550.7950.9146.0750.712.2K
10 Oct 2550.7050.8646.6246.621.7K
09 Oct 2550.5650.5845.9150.581.5K
08 Oct 2549.6749.6849.6749.68500
07 Oct 2550.4050.5650.1250.12900
06 Oct 2553.5453.7048.9251.092.6K
03 Oct 2547.6647.6647.2047.201.2K
02 Oct 2543.8845.8643.7245.8618.2K

COMPANY PROFILE

Name:Chugai Pharmaceutical Co. Ltd
About:Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. It offers oncology products, such as Alecensa, Avastin, FoundationOne, Herceptin, Kadcyla, Lunsumio, Perjeta, Polivy, Tecentriq, and Phesgo; Neutrogin and Sigmart; Actemra for humanized anti-human IL-6 receptor monoclonal antibody; CellCept for immunosuppressant; Edirol, an osteoporosis agent; Enspryng, a pH-dependent binding humanized anti-IL-6 receptor monoclonal antibody; Evrysdi for spinal muscular atrophy agent; Hemlibra, an anti-coagulation factor IXa/X humanized bispecific monoclonal antibody; Mircera, an erythropoiesis-stimulating agent; PiaSky, a pH-dependent binding humanized anti-complement (C5) monoclonal antibody; Ronapreve, an anti-SARS-CoV-2 monoclonal antibody; Tamiflu, an anti-influenza agent; and Vabysmo, an anti VEGF/anti Ang-2 bispecific antibody. The company has strategic alliances and collaboration with Roche Group; and research and license agreement with Gero PTE. LTD. to develop novel therapies for age-related diseases. The company was formerly known as Chugai Shinyaku Shokai and changed its name to Chugai Pharmaceutical Co., Ltd. in January 1943. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.
Sector:Healthcare
Address:Nihonbashi Mitsui Tower, Chuo, Japan, 103-8324
Website:https://www.chugai-pharm.co.jp
CIK:0001453934
FIGI:BBG000C0DPL2

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:29.13 
Forward P/E:25.25 
DivYield:0.01 
Div/Share:107.00 
Price to Book:5.63 
Price to Sales:0.07 
EBITDA:588.813B 
Shares:1.646B 
Market Cap:79.965B 

TECHNICAL INDICATORS

MA5:49.111.1%
MA10:48.950.7%
MA20:46.614.2%
MA50:44.918.2%
MA100:47.522.2%
MA200:47.681.9%
STO9:27.82
STO14:59.38
RSI14:62.12 
WPR14:-25.08
MTM14:4.16
ROC14:0.09 
ATR:3.61 
Week High:50.914.8%
Week Low:43.5611.5%
Month High:53.7010.5%
Month Low:39.661.9%
Year High:72.3048.8%
Year Low:32.2550.7%
Volatility:62.42 

RECENT SPLITS

Date Ratio
29 Jun 20203-1